Titan Pharmaceuticals, Inc. (TTNP)
USD 3.45
(0.29%)
USD 3.45
(0.29%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 184 Thousand | 60 Thousand | 1.52 Million | 4.83 Million | 3.61 Million | 5.91 Million |
| Cost of Revenue | 1.91 Million | 196 Thousand | 199 Thousand | 472 Thousand | 1.28 Million | 538 Thousand |
| Gross Profit | -1.72 Million | -136 Thousand | 1.32 Million | 4.36 Million | 2.32 Million | 5.37 Million |
| Operating Expenses | 7.46 Million | 10.29 Million | 10.68 Million | 11.71 Million | 19.16 Million | 13.63 Million |
| Selling, General and Administrative Expenses | 5.54 Million | 6.03 Million | 4.98 Million | 5.8 Million | 11.92 Million | 6.86 Million |
| Research and Development Expenses | 1.91 Million | 4.75 Million | 5.69 Million | 5.91 Million | 7.24 Million | 7.47 Million |
| Other Expenses | - | -497 Thousand | -84 Thousand | 1.71 Million | 17 Thousand | -6000.00 |
| Cost and Expenses | 7.46 Million | 10.29 Million | 10.88 Million | 12.18 Million | 20.45 Million | 14.17 Million |
| Operating Income | -7.27 Million | -10.23 Million | -9.35 Million | -7.35 Million | -16.84 Million | -8.26 Million |
| Interest Expense | - | - | 1000.00 | 769 Thousand | 967 Thousand | 887 Thousand |
| Income Tax Expense | - | -29 Thousand | -662 Thousand | 13.32 Million | -369 Thousand | -1.64 Million |
| Earnings before Tax | -5.56 Million | -10.2 Million | -8.77 Million | -7.4 Million | -16.45 Million | -9.02 Million |
| Net Income | -5.56 Million | -10.17 Million | -8.11 Million | -20.72 Million | -16.08 Million | -9.02 Million |
| Earnings Per Share Basic | -7.41 | -15.15 | -16.68 | -109.88 | -12.6 Thousand | -47.59 |
| Earnings Per Share Diluted | -7.41 | -15.15 | -16.68 | -109.88 | -12.6 Thousand | -47.59 |
| Weighted Average Shares Outstanding | 752 Thousand | 671.7 Thousand | 486.5 Thousand | 188.65 Thousand | 1276.67 | 189.59 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 752 Thousand | 671.7 Thousand | 486.5 Thousand | 188.65 Thousand | 1276.67 | 189.59 Thousand |
| Gross Margin | -9.40 | -2.27 | 0.87 | 0.90 | 0.64 | 0.91 |
| EBIT Margin | -38.94 | -167.32 | -6.42 | -1.10 | -4.97 | -1.36 |
| Profit Margin | -30.27 | -169.62 | -5.32 | -4.28 | -4.46 | -1.53 |
| EBITDA | -7.16 Million | -10.03 Million | -9.13 Million | -7.05 Million | -6.27 Million | -7.88 Million |
| Earnings Before Tax Margin | -39.55 | -170.58 | -6.13 | -1.52 | -4.66 | -1.40 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 81 Thousand | 184 Thousand | 4000.00 | 1000.00 |
| Cost of Revenue | 3000.00 | 2000.00 | 3000.00 | 112 Thousand | 27 Thousand | 442 Thousand |
| Gross Profit | -3000.00 | -2000.00 | 78 Thousand | 72 Thousand | -23 Thousand | -441 Thousand |
| Operating Expenses | 2.07 Million | 1.06 Million | 1.92 Million | 7.34 Million | 2.06 Million | 1.58 Million |
| Selling, General and Administrative Expenses | 2.07 Million | 1.06 Million | 1.44 Million | - | 1.64 Million | 1.22 Million |
| Research and Development Expenses | - | - | 487 Thousand | - | 424 Thousand | 442 Thousand |
| Other Expenses | -19 Thousand | 2000.00 | -49 Thousand | -52 Thousand | 2000.00 | -5000.00 |
| Cost and Expenses | 2.07 Million | 1.06 Million | 1.93 Million | 7.46 Million | 2.06 Million | 1.58 Million |
| Operating Income | -2.07 Million | -1.06 Million | -1.93 Million | -7.27 Million | -2.06 Million | -1.58 Million |
| Interest Expense | - | - | 33 Thousand | - | -11 Thousand | - |
| Income Tax Expense | - | -41.27 Thousand | 1.75 Million | -55.89 Thousand | -1.72 Million | -7000.00 |
| Earnings before Tax | -2.09 Million | -1.06 Million | -1.97 Million | -5.56 Million | -338 Thousand | -1.58 Million |
| Net Income | -2.09 Million | -1.06 Million | -1.97 Million | -5.56 Million | -338 Thousand | -1.58 Million |
| Earnings Per Share Basic | -2.29 | -1.24 | -2.52 | - | -0.45 | -2.11 |
| Earnings Per Share Diluted | -2.29 | -1.24 | -2.52 | - | -0.45 | -2.11 |
| Weighted Average Shares Outstanding | 914 Thousand | 853 Thousand | 781.5 Thousand | 752 Thousand | 750.8 Thousand | 750.8 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 914 Thousand | 853 Thousand | 781.5 Thousand | 752 Thousand | 750.8 Thousand | 750.8 Thousand |
| Gross Margin | - | - | 0.96 | 0.39 | -5.75 | -441.00 |
| EBIT Margin | - | - | -23.80 | - | -941.50 | -1549.00 |
| Profit Margin | - | - | -24.32 | -30.27 | -84.50 | -1586.00 |
| EBITDA | -2.07 Million | -1.06 Million | -1.92 Million | - | -3.76 Million | -1.54 Million |
| Earnings Before Tax Margin | - | - | -23.84 | -39.55 | -515.25 | -1588.00 |
LAMDA
300570
GBMIF
PKCOY
MBGAF
DBLVF